SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

SPY is trending amid intensifying Middle East geopolitical tensions, driving widespread debate about the potential for spiking oil prices and their impact on inflation and future Fed rate decisions. The community remains sharply divided, with some anticipating a significant market correction after earlier strength, while others expect a "buy the dip" opportunity despite concerns of market manipulation.

Battalion Oil Corp. engages in the acquisition, production, exploration, and development of liquids-rich oil and natural gas assets in the Delaware Basin. The company was founded in 1987 and is headquartered in Houston, TX.

Battalion Oil Corp - Ordinary Shares (New)

Battalion Oil Corp is presently trending due to escalating geopolitical tensions in the Middle East driving up oil and natural gas prices, sparking widespread community discussion around a significant short squeeze and expectations for continued parabolic appreciation.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is highly volatile amid escalating Middle East geopolitical tensions, with an Iranian official claiming the Strait of Hormuz is closed and reports of attacks on US assets. The community is fiercely divided, with many "buying the dip" after recent "V-pumps" while others warn of an impending "blood bath" driven by concerns over oil prices and tech sector overvaluation.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology Group Inc. is trending as the community eagerly anticipates its upcoming full-year 2025 financial results, with significant discussion around whether projected record revenues and profitability improvements will finally translate into positive stock action. While many express frustration over past market reactions despite strong fundamentals and a multi-billion dollar AI infrastructure pipeline, a core group of investors remains highly optimistic about the company's long-term value proposition and potential for a short squeeze.

AeroVironment, Inc. engages in the design, development, and production of multi-domain robotic systems and related services for government agencies and businesses. It operates through the following business segments: UnCrewed Systems, Loitering Munitions Systems, and MacCready Work. The UnCrewed Systems segment focuses primarily on small UAS products designed to operate reliably at lower altitudes in a wide range of environmental conditions. The Loitering Munitions Systems segment focuses primarily on tube-launched aircraft that deploy with the push of a button, fly at higher speeds than small UAS products, and perform either effects delivery or reconnaissance missions, and related support services including training, spare parts, product repair, and product replacement. The MacCready Works segment focuses on customer-funded research and development in the areas of HAPS, robotics, sensors, software analytics, data intelligence, and connectivity. The company was founded by Paul B. MacCready, Jr. in July 1971 and is headquartered in Arlington, VA.

AeroVironment Inc.

AeroVironment is trending after an analyst downgrade, driven by news of its largest U.S. Space Force contract being recompeted, which caused a sharp sell-off that many in the community view as an overreaction or market manipulation given the company's defense market position.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

GLD is trending as escalating Middle East tensions are driving discussions around its role as a key safe-haven asset, with the community actively debating whether the current rally to historical highs is sustainable or an overextended surge amid fears of manipulation and broader market rotation.

Pinterest, Inc. engages in the operation of a pinboard-style photo-sharing website. It allows users to create and manage theme-based image collections such as events, interests, and hobbies. The company was founded by Benjamin Silbermann, Paul C. Sciarra, and Evan Sharp in October 2008 and is headquartered in San Francisco, CA.

Pinterest Inc - Ordinary Shares - Class A

Pinterest Inc

Pinterest is trending due to activist investor Elliott Management's $1 billion investment and the announcement of a new $3.5 billion share repurchase program, including a $1 billion accelerated buyback. This significant capital return strategy, seen as a strong vote of confidence and a catalyst for value, is generating widespread excitement and discussion about the company's future.

Indonesia Energy Corp. Ltd. operates as an oil and gas, exploration, and production company. It engages in oil and gas assets portfolio with a mix between medium-sized producing blocks and exploration blocks with significant resources. Its portfolio includes Kruh, Citarum, and Rangkas Area. The company was founded by James J. Huang and Wirawan Jusuf in 2014 and is headquartered in Jakarta, Indonesia.

Indonesia Energy Corp Ltd

INDO is trending as the escalating Middle East conflict and threats to the Strait of Hormuz propel oil prices higher, leading the community to anticipate a significant run and potential short squeeze, drawing comparisons to other surging oil stocks. Investors are actively debating whether INDO will follow its peers, while also looking forward to upcoming drilling updates from the company.

Sea Ltd. is an internet and mobile platform company, which engages in the provision of online gaming services. It operates through the following segments: Digital Entertainment, E-Commerce, and Digital Financial Services. The Digital Entertainment segment offers and develops mobile and PC online games. The E-Commerce segment manages a third-party marketplace through the Shopee mobile app and websites that connect buyers and sellers. The Digital Financial Services segment includes a variety of payment services and loans to individuals and businesses through SeaMoney. Sea was founded by Xiao Dong Li, Gang Ye, and Jing Ye Chen on May 8, 2009 and is headquartered in Singapore.

Sea Ltd - ADR

Sea Ltd is trending following its Q4 2025 earnings, which showed strong revenue and profit growth but also an EPS miss that has led to a contentious market reaction, with many in the community questioning the sell-off despite optimistic guidance for Shopee's continued expansion.

MongoDB, Inc. engages in the development and provision of a general-purpose database platform. The firm's products include MongoDB Enterprise Advanced, MongoDB Atlas, and Community Server. It also offers professional services including consulting and training. The company was founded by Eliot Horowitz, Dwight A. Merriman, Kevin P. Ryan, and Geir Magnusson Jr. in November 2007 and is headquartered in New York, NY.

MongoDB Inc - Ordinary Shares - Class A

MongoDB Inc

MongoDB is facing significant pressure following its Q4 earnings report, with the stock seeing a sharp decline fueled by conservative Q1 guidance and news of key executive departures. This has sparked intense community debate, as some view the sell-off as an overreaction and a potential buying opportunity, while others highlight concerns over slowing growth and broader SaaS sector uncertainty.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Indaptus Therapeutics, Uipath, Trinity Biotech, Sable Offshore And McDonald's: Why These 5 Stocks Are On Investors' Radars Today

INDP, PATH, TRIB, SOC, MCD were among the stocks seen among investors on Tuesday, Dec. 23, 2025.read more...

<ul class="summary-bullets"><li>Trinity Biotech’s shares were up nearly 47% in Tuesday’s midday trade after the company announced that it had secured an order for nine million units of its TrinScreen HIV rapid diagnostic test.</li><li>Starfighters Space shares were down over 51% in Tuesday’s midday session, taking a breather after a massive 371% rally on Monday.</li><li>VisionWave shares were up nearly 8% in Tuesday’s midday trade after the company announced the issuance of a new patent that covers the systems and methods for real-time movement, position detection, and imaging technology.</li></ul>U.S. equities traded in the green on Tuesday noon amid optimism about a Santa Claus rally, with the Dow Jones Industrial Average, S&amp;P 500, and the Nasdaq Composite on course for their fourth consecutive winning session.Earlier in the day, the Bureau of Economic Analysis&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/us-gdp-q3-december-2025/cLep8gzREuU">reported</a> that the U.S. economy grew at an annualized rate of 4.3%, higher than the Dow Jones forecast of 3.2%, as&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/us-gdp-q3-december-2025/cLep8gzREuU">cited</a> by MarketWatch.The&nbsp;<a href="https://stocktwits.com/symbol/SPY">SPDR S&amp;P 500 ETF</a> (SPY), which mirrors the S&amp;P 500 index, was up 0.28% at the time of writing, while the&nbsp;<a href="https://stocktwits.com/symbol/QQQ">Invesco QQQ Trust</a> (QQQ), which mirrors the Nasdaq 100 index, gained 0.25%. The&nbsp;<a href="https://stocktwits.com/symbol/DIA">SPDR Dow Jones Industrial Average ETF Trust</a> (DIA), which tracks the Dow Jones Industrial Average, rose 0.18%.<h2 class="st-heading-2">Here are the top stocks making the biggest moves in Tuesday’s midday trade:</h2><a href="https://stocktwits.com/symbol/NVO">Novo Nordisk AS (NVO)</a>Novo Nordisk shares were up more than 9% in Tuesday’s midday session after the company&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/novo-nordisk-stock-soars-after-hours-as-fda-greenlights-wegovy-pill-for-weightloss/cLeFw1kREu2">said</a> that its Wegovy pill for weight loss has been approved by the U.S. Food and Drug Administration (FDA), making it the first oral GLP-1 class drug for weight management approved by the agency.<a href="https://stocktwits.com/symbol/NVO">NVO stock</a> is down 39% year-to-date.<a href="https://stocktwits.com/symbol/TRIB">Trinity Biotech Plc. (TRIB)</a>Trinity Biotech’s shares were up nearly 47% in Tuesday’s midday trade after the company&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/why-did-trinity-biotech-stock-surge-nearly-50-in-premarket-today/cLepnI7REuv">announced</a> that it had secured an order for nine million units of its TrinScreen HIV rapid diagnostic test, scheduled for delivery in the fourth quarter (Q4) of 2025 and the first quarter (Q1) of 2026.<a href="https://stocktwits.com/symbol/TRIB">TRIB stock</a> is up 48% year-to-date.<a href="https://stocktwits.com/symbol/FJET">Starfighters Space Inc. (FJET)</a>Starfighters Space shares were&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/fjet-stock-takes-a-breather-post-massive-rally/cLepsN8REH7">down</a> over 51% in Tuesday’s midday session, taking a breather after a massive 371% rally on Monday. The company laid out its 2026 plans, stating that the convergence of government demand, growth in the commercial space segment, and public market access following its IPO positions it well.<a href="https://stocktwits.com/symbol/FJET">FJET stock</a> is up 56% year-to-date.<a href="https://stocktwits.com/symbol/VWAV">VisionWave Holdings Inc. (VWAV)</a>VisionWave shares were up nearly 8% in Tuesday’s midday trade after the company announced the issuance of a new patent that covers the systems and methods for real-time movement, position detection, and imaging technology.<a href="https://stocktwits.com/symbol/VWAV">VWAV stock</a> is up 263% year-to-date.<a href="https://stocktwits.com/symbol/NOW">ServiceNow Inc. (NOW)</a>ServiceNow shares were down nearly 3% in Tuesday’s midday session after the company&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/service-now-acquires-armis-in-7-75-billion-deal-to-strengthen-ai-powered-security-platform/cLepYSLREHb">announced</a> the acquisition of cybersecurity startup Armis in a $7.75 billion deal as it looks to bolster its offerings amid rising threats due to the expanding use of AI.<a href="https://stocktwits.com/symbol/NOW">NOW stock</a> is down 28% year-to-date.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/fjet-stock-takes-a-breather-post-massive-rally/cLepsN8REH7">FJET Stock Takes A Breather Post Massive Rally – Starfighters Space Releases 2026 Plans After Stock Market Debut</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

A bull statue and a bear statue stand outside the Frankfurt Stock Exchange on April 7, 2025 in Frankfurt, Germany

Novo Nordisk, Trinity Biotech, Starfighters Space, VisionWave, ServiceNow: Stocks Making The Biggest Moves Today

Novo Nordisk shares were up more than 9% in Tuesday’s midday session after the company said that the U.S. FDA has approved its Wegovy pill for weight loss.

Equity

<ul class="summary-bullets"><li>Trinity posted a 32% sequential increase in third-quarter revenue to $14.3 million, driven by a $2.1 million increase in rapid HIV test sales.</li><li>The company entered into new financing agreements with funds managed by Perceptive Advisors.</li><li>The deal includes $5 million in new term-loan funding and up to $60 million in elective equitization capacity.</li></ul>Trinity Biotech (TRIB) shares surged nearly 50% in premarket trading on Tuesday, after the company said it had secured an order for 9 million units of its TrinScreen HIV rapid diagnostic test.The WHO-prequalified rapid diagnostic test is designed for high-volume screening programs and will be produced through the company’s recently approved outsourced manufacturing process. Trinity Biotech expects to fulfil the order across the fourth quarter of 2025 and the first quarter of 2026, with the contract set to support revenue growth.<a href="https://stocktwits.com/symbol/TRIB">Trinity Biotech</a> also posted a 32% sequential increase in third-quarter revenue to $14.3 million, driven by a $2.1 million increase in rapid HIV test sales, while adjusted EBITDA improved to a $0.5 million profit from a $2.1 million loss in Q2.The company said it continues to advance its transformation plan after securing key regulatory approvals, including WHO authorization to outsource production of its Uni-Gold HIV rapid test. These milestones are expected to drive efficiency gains and support rising adjusted EBITDA through the first half of 2026."Our operating and financial improvement in Q3 2025 was encouraging, in particular the achievement of positive Adjusted EBITDA. This gives us confidence that our Comprehensive Transformation Plan is on track and, when combined with our exciting innovation agenda, leaves the business well positioned for further progress in 2026,” said John Gillard, CEO of Trinity Biotech. &nbsp;<h2 class="st-heading-2">Trinity's Financing Plans</h2>Trinity Biotech also entered into new financing agreements with funds managed by Perceptive Advisors to strengthen liquidity and improve capital structure flexibility.&nbsp;The deal includes $5 million in new term-loan funding and up to $60 million in elective equitization capacity, which could lower debt and interest costs. The agreements also introduce equity-based settlement options for certain obligations, supporting Trinity Biotech’s long-term growth and investment plans.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment flipped to 'extremely bullish' from 'extremely bearish' a day earlier, amid 'extremely high' message volumes.<img src="https://news.stocktwits-cdn.com/TRIB_png_e777e3d7ee.webp" alt="TRIB.png">One user sees $1.75 as a key resistance point.<stembedurl>https://stocktwits.com/TeamBullish/message/639966430</stembedurl>Year-to-date, the stock has gained 43%.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Why Did Trinity Biotech Stock Surge Nearly 50% In Premarket Today?

Trinity Biotech (TRIB) shares surged nearly 50% in premarket trading on Tuesday, after the company said it had secured an order for 9 million units of its TrinScreen HIV rapid diagnostic test.

The company secured an order for 9 million units of its TrinScreen HIV rapid diagnostic test.

Trinity Biotech's Redesigned CGM Sensor Favored by New Clinical Data

TRIB's needle-free CGM+ sensor shows accurate 15-day results with no calibration, slashing costs and boosting access.

Trinity Biotech&nbsp;notched its best session on record on Thursday after its New York reference laboratory received approval from the New York State Department of Health to begin offering the FDA-cleared PreClara Ratio biomarker test for assessing the risk of preeclampsia.&nbsp;Shares of Trinity Biotech soared 89.1% to $1.9 on Thursday, marking its best session since the company’s launch in 1992, before sliding 16% to $1.6 in after-hours trading. Additionally, trading volume in Trinity surged to 208.5 million shares on Thursday, more than 1,160 times its average daily volume of 178,948.The service, which has a planned release in the third quarter (Q3) of 2025, is expected to support clinicians in making more rapid and informed decisions for patients hospitalized with hypertensive disorders of pregnancy, a complex set of conditions that impacts approximately 500,000 women annually in the U.S.&nbsp;The test, by estimating the risk of progression to severe preeclampsia, can enable earlier and more precise interventions.&nbsp;Research published in March estimated the potential to achieve more than $10 million in neonatal cost savings per 1,000 patients with the test as part of standard care, largely due to a reduction in preterm births and NICU days.The approval also paves the way for Trinity's expected launch of PrePsia, its proprietary technology that screens for preeclampsia risk earlier in pregnancy.&nbsp;Preeclampsia is estimated to affect 5–8% of pregnancies. The condition is a major driver of maternal and neonatal complications in the U.S., accounting for approximately 11% of maternal deaths and 15% of premature births.The PreClara Ratio is designed for use alongside other laboratory tests and clinical assessments in women between 23 and nearly 35 weeks of pregnancy who are hospitalized with hypertensive disorders.&nbsp;It calculates a ratio from specific blood test results to estimate the short-term risk of developing severe preeclampsia.On Stocktwits, retail sentiment for Trinity Biotech was ‘extremely bullish’ amid a 7,211% surge in 24-hour message volume.One user remarked that they expected Trinity Biotech to climb back over $3.00 the next day, urging others to “buy the dips and hold,” adding that all short shares were accounted for and the stock “can rip and halt like it did today.”&nbsp;<stembedurl>https://stocktwits.com/Magicians/message/625281470</stembedurl>Another user speculated that the sharp rise could be followed by a dilution announcement, noting the stock was now “going down on huge volume.”&nbsp;<stembedurl>https://stocktwits.com/Huskersnsaints/message/625247540</stembedurl>A third user predicted it could “easily break $4.00” going into the next session, recommending buying at market price and holding.<stembedurl>https://stocktwits.com/Magicians/message/625225289</stembedurl>Trinity Biotech’s stock has more than doubled so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Shares of Trinity Biotech (TRIB) soared 89.1% to $1.9 on Thursday, marking its best session since the company’s launch in 1992. (Photo credit: Getty Images)

Trinity Biotech Stock Marks Best Day Ever On New York Greenlight For Pregnancy Risk Test; Retail Sees More Upside

Trading volume in Trinity Biotech spiked to more than 1,160 times its daily average after regulators cleared the PreClara Ratio test, which helps doctors identify pregnant patients at risk of developing severe preeclampsia.

Three nano-cap healthcare stocks drew massive attention from retail investors on Stocktwits Tuesday, though not all for positive reasons.Trinity Biotech (<a href="https://stocktwits.com/symbol/TRIB">TRIB</a>)&nbsp;Shares of the medical diagnostic products maker saw a staggering 15,550% jump in retail message volume after the company released “compelling” results from a study on its next-generation continuous glucose monitoring system.&nbsp;The device, designed for real-time diabetes management, demonstrated superior signal quality, accuracy, and consistency in a trial involving 30 diabetic participants.&nbsp;The system features a reusable applicator and rechargeable wearable transmitter, reducing costs by eliminating disposable components.&nbsp;Trinity said it remains on track to seek regulatory approval in the EU by 2025 and the U.S. by 2026.&nbsp;Shares fell over 13% premarket Wednesday.Silexion Therapeutics (<a href="https://stocktwits.com/symbol/SLXN">SLXN</a>)&nbsp;The cancer-focused biotech firm’s ticker saw a 9,060% surge in retail message volume as its stock more than doubled Tuesday following promising preclinical data for its tumor drug candidate SIL-204.&nbsp;The company reported that the extended-release formulation of SIL-204 reduced tumor growth by more than 50% after 30 days, with around 50% of tumors showing complete necrosis in human pancreatic models.&nbsp;Additionally, an injectable version of the drug candidate showed tumor growth inhibition in metastatic pancreatic mouse models.&nbsp;The stock continued its rally, gaining over 70% premarket Wednesday.Sharps Technology (<a href="https://stocktwits.com/symbol/STSS">STSS</a>)&nbsp;The medical packaging firm experienced a 6,233% surge in retail message volume, but for the wrong reasons.&nbsp;Shares plunged nearly 70% to a record low on Tuesday after the company announced a $20 million public offering of 14,285,714 Common Units.&nbsp;Each unit consists of one share of common stock, one Series A warrant, and one Series B warrant, priced at $1.40 per unit, a 4.1% discount to Monday’s close.&nbsp;The company said the proceeds would be used for general corporate purposes and working capital.&nbsp;The stock continued to slide, down over 2% premarket Wednesday.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Stockbroker analyzing financial stock market with reflection on eyeglasses. Photo via Westend61 on Getty Images

TRIB, SLXN, STSS: Why Retail Chatter On 3 Nano-Cap Healthcare Stocks Exploded Over 6000%

“Compelling” results from a study, promising pre-clinical data and a public offering got Stocktwits investors buzzing on Tuesday.

Trinity Biotech Plc engages in the development, manufacture, and marketing of medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market. It operates through the Americas and Rest of World geographical segments. The company was founded by Ronan O'Caoimh and Denis R. Burger in June 1992 and is headquartered in Bray, Ireland.

Trinity Biotech Plc - ADR

Beat EPS and revenue

Beat EPS, miss revenue

Miss EPS, beat revenue

Miss EPS and revenue

What do you expect from $MDB earnings today?

Current Price	$0.69
Prev Close	$0.7195
Open	$0.70
Dividend Yield	0.00%
50-Day Moving Average	$0.8042
Beta	0.60
Avg. Volume	175,275.64
PE Ratio	-0.29

52-Week High	$3.44
52-Week Low	$0.48
Market Capitalization	$12.86M
EPS (Annual)	-$1.77
Price to Book	-0.23
Revenue Per Employee	$153,232.58

TRIB
Trinity Biotech plc

Feed

News

Sentiment

Fundamentals

Info

Latest TRIB News

TRIBTrinity Biotech plc